ACONW ACONW 深 沪
已收盘 08-01 16:00:00 美东时间
0.0284
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0284
- 总市值 0
- 52周最高 0.2446
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.01
- 委 比 -13.39%
- 总股本 --
- 历史最高 1.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.0051
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aclarion Launches Major US Trial to Test AI Tool That Could Improve Spine Surgery for Chronic Back Pain
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the
06-25 18:02
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
Aclarion, Inc. announced the initiation of the CLARITY trial, enrolling the first patient at the Texas Back Institute. This randomized clinical trial evaluates Nociscan's ability to improve surgical outcomes for chronic low back pain using MR Spectroscopy and AI. Aiming to become the gold standard, Nociscan identifies pain sources non-invasively.中期结果预计在2026年第二季度公布。The trial involves 300 patients across multiple sites, focusing on discogenic low b...
06-25 10:00
Aclarion Adds USC's Keck Medical Center to Spine Pain Study, Joining Johns Hopkins, Northwestern
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the
05-20 18:05
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
BROOMFIELD, CO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or...
2024-08-15 21:48
Aclarion Presents at the NIH HEAL Initiative Fall Meeting
The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, is f...
2023-11-01 08:00
Aclarion Announces Signing Of Commercial Agreement With Porter Hospital, An AdventHealth facility, To Bring Nociscan Technology To Denver
Porter Hospital Becomes First Facility in Denver to Give Chronic Low Back Pain Patients Access to Revolutionary Nociscan Technology That Measures Biomarkers to Pinpoint the Source of PainGeorge Frey, MD Becomes
2023-10-25 20:31
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
BROOMFIELD, CO, Aug. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion,...
2023-08-26 04:10
Aclarion 将于 2023 年 2 月 21 日至 24 日出席第三届年度冬季仙境——最佳创意虚拟投资者会议
BROOMFIELD, CO / ACCESSWIRE / February 16, 2023 / Aclarion, Inc., ("Aclarion" o...
2023-02-16 20:02
